SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein Occlusion.

[1]  I. Scott,et al.  Month 60 Outcomes after Treatment Initiation with Anti-VEGF Therapy for Macular Edema due to Central or Hemi-Retinal Vein Occlusion. , 2022, American journal of ophthalmology.

[2]  D. Grewal,et al.  Visual Acuity in Retinal Vein Occlusion-, Diabetic-, and Uveitic Macular Edema: Central Subfield Thickness and Ellipsoid Zone Analysis. , 2020, Ophthalmology. Retina.

[3]  I. Scott,et al.  Month 24 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial. , 2019, JAMA ophthalmology.

[4]  I. Scott,et al.  Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial , 2017, JAMA.

[5]  I. Scott,et al.  SCORE2 Report 2: Study Design and Baseline Characteristics. , 2017, Ophthalmology.

[6]  Vito M. R. Muggeo,et al.  Testing with a nuisance parameter present only under the alternative: a score-based approach with application to segmented modelling , 2016 .

[7]  N. Bressler,et al.  Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema. , 2014, JAMA ophthalmology.

[8]  Glenn J Jaffe,et al.  Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. , 2013, Ophthalmology.

[9]  Y. Ogura,et al.  VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study , 2013, British Journal of Ophthalmology.

[10]  J. Haller,et al.  Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study. , 2012, Ophthalmology.

[11]  P. Campochiaro,et al.  Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.

[12]  M. Blumenkranz,et al.  Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. , 2010, Ophthalmology.

[13]  Sarah Gray,et al.  Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.

[14]  Ingrid U Scott,et al.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. , 2009, Archives of ophthalmology.

[15]  Vikram S Brar,et al.  Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis). , 2009, American journal of ophthalmology.

[16]  I. Scott,et al.  SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. , 2009, Ophthalmology.

[17]  Jennifer I. Lim,et al.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. , 2007, Ophthalmology.

[18]  S. Sacu,et al.  Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study. , 2005, Acta ophthalmologica Scandinavica.

[19]  L. D. Del Priore,et al.  INTRAVITREAL TRIAMCINOLONE TREATMENT FOR MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION AND HEMIRETINAL VEIN OCCLUSION , 2005, Retina.

[20]  M. Isola,et al.  “Light” versus “classic” laser treatment for clinically significant diabetic macular oedema , 2005, British Journal of Ophthalmology.

[21]  H. Hayashi,et al.  Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. , 2005, American journal of ophthalmology.

[22]  C. Bunce,et al.  Vitrectomy and radial optic neurotomy for central retinal vein occlusion: effects on visual acuity and macular anatomy , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[23]  S. Takeuchi,et al.  Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion. , 2004, American journal of ophthalmology.

[24]  A. Nonaka,et al.  Delayed absorption of macular edema accompanying serous retinal detachment after grid laser treatment in patients with branch retinal vein occlusion. , 2004, Ophthalmology.

[25]  B. Sander,et al.  Subthreshold micropulse diode laser treatment in diabetic macular oedema , 2004, British Journal of Ophthalmology.

[26]  J. Garcia-Arumi,et al.  MANAGEMENT OF MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSION WITH SHEATHOTOMY AND RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR , 2004, Retina.

[27]  C. Puliafito,et al.  Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. , 2004, Archives of ophthalmology.

[28]  P. Radice,et al.  Optical coherence tomography evaluation of macular edema after radial optic neurotomy in patients affected by central retinal vein occlusion , 2004, Seminars in ophthalmology.

[29]  Ali Erginay,et al.  Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. , 2003, American journal of ophthalmology.

[30]  W. Goebel,et al.  RETINAL THICKNESS IN DIABETIC RETINOPATHY: A Study Using Optical Coherence Tomography (OCT) , 2002, Retina.

[31]  J. Duker,et al.  Intravitreal triamcinolone for refractory diabetic macular edema. , 2002, Ophthalmology.

[32]  S. Kishi,et al.  Patterns of diabetic macular edema with optical coherence tomography. , 1999, American journal of ophthalmology.

[33]  J. Duker,et al.  Imaging of macular diseases with optical coherence tomography. , 1995, Ophthalmology.

[34]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.

[35]  M. Muggeo,et al.  segmented: An R package to Fit Regression Models with Broken-Line Relationships , 2008 .

[36]  W. Cleveland,et al.  Regression by local fitting: Methods, properties, and computational algorithms , 1988 .